Join
Live feed
·
PRReleasevia Quantisnow
Hoth Therapeutics Inc. logo

Hoth Therapeutics Signs VA Research Deal to Advance GDNF as Breakthrough Therapy for Obesity and Fatty Liver - Side-by-Side Study vs. Semaglutide Begins

ByQuantisnow·Wall Street's wire, on your screen.
HOTH· Hoth Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HOTH (Hoth Therapeutics Inc.) and more on Quantisnow.